Rheumatic fever screening

Revision as of 00:00, 30 July 2020 by WikiBot (talk | contribs) (Bot: Removing from Primary care)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Rheumatic fever Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Rheumatic Fever from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

Jones Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Case Studies

Case #1

Rheumatic fever screening On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Rheumatic fever screening

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Rheumatic fever screening

CDC on Rheumatic fever screening

Rheumatic fever screening in the news

Blogs on Rheumatic fever screening

Directions to Hospitals Treating Rheumatic fever

Risk calculators and risk factors for Rheumatic fever screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Varun Kumar, M.B.B.S. [2]; Anthony Gallo, B.S. [3]

Overview

Screening of rheumatic fever is important as many cases of rheumatic heart disease are subclinical. Echocardiography among inhabitants of high risk regions is recommended. If any abnormality is detected on echocardiography, further cardiac evaluation is performed followed by antimicrobial therapy.

Screening

References

  1. Marijon E, Ou P, Celermajer DS, Ferreira B, Mocumbi AO, Sidi D; et al. (2008). "Echocardiographic screening for rheumatic heart disease". Bull World Health Organ. 86 (2): 84. PMC 2647380. PMID 18297157.
  2. Meira ZM, Goulart EM, Colosimo EA, Mota CC (2005). "Long term follow up of rheumatic fever and predictors of severe rheumatic valvar disease in Brazilian children and adolescents". Heart. 91 (8): 1019–22. doi:10.1136/hrt.2004.042762. PMC 1769032. PMID 16020588.

Template:WH Template:WS